Quest Diagnostics Incorporated
Health
Performance
2.3
Risk
Sell
Buy
Curious about the Scores? Learn more.

Quest Diagnostics Incorporated stock rating and score history

All changes in ratings, performance and outlook tracked over time.

17.07.2026
Picking up speed. Momentum turning positive.
30.06.2026
From weak to decent. The first signs are finally showing.
14.02.2026
Still low-risk, but small tremors appearing.
20.08.2025
Health’s picking up. Numbers look cleaner, cash flow tighter.
DGX
Quest Diagnostics Incorporated
207.66
-1.43%
2.3
Sell
Buy
Quest Diagnostics Incorporated

Quest Diagnostics Incorporated stock price, chart patterns and momentum

Recent price movements, trend behaviour and momentum signals based on real-time market data.

What does Quest Diagnostics Incorporated do? Business model and key facts

Get the full picture of Quest Diagnostics Incorporated: what it builds, where it operates, and how it makes money.

Quest Diagnostics Incorporated Profile

Sector: Healthcare

Industry: Medical - Diagnostics & Research

Employees (FY): 57000

Quest Diagnostics Incorporated, founded in 1967 and headquartered in Secaucus, New Jersey, is a premier provider of diagnostic testing, information, and related services, serving clients both domestically and internationally. Its core business involves the development and provision of diverse diagnostic information services, such as routine, advanced clinical, and anatomic pathology testing. While primarily operating under the Quest Diagnostics brand, it also leverages specialized identities like AmeriPath, Dermpath Diagnostics, ExamOne, and Quanum to reach a broad spectrum of clients. Its extensive client base includes patients, clinicians, hospitals, integrated delivery networks, health plans, employers, and other direct healthcare entities. Delivery of these services is facilitated through a robust network comprising laboratories, patient service centers, in-office phlebotomists, call centers, and mobile health professionals including paramedics and nurses. Additionally, the company provides risk assessment services for the life insurance industry and offers comprehensive information technology solutions to healthcare organizations and clinicians.

shop
Company facts
James E. Davis
CEO
57000
Employees worldwide
shop
Performance
24.76%
Last 12 months
52.39%
Last 5 years
shop
Growth
$11.04B
Revenue year
$1.05B
Net income
shop
Valuation
$23.32B
Market Cap
19.56
Price/Earnings Ratio

Stocks related to Quest Diagnostics Incorporated

Selected based on industry alignment and relative market positioning.

WAT
Waters Corporation
357.54
-3.10%
4.1
Sell
Buy
Waters Corporation
MTD
Mettler-Toledo International Inc.
1,273.77
-2.77%
5.3
Sell
Buy
Mettler-Toledo International Inc.
ILMN
Illumina, Inc.
184.68
-1.06%
5.3
Sell
Buy
Illumina, Inc.
LH
Labcorp Holdings Inc.
281.48
-0.66%
2.2
Sell
Buy
Labcorp Holdings Inc.
GH
Guardant Health, Inc.
148.07
-5.00%
8.2
Sell
Buy
Guardant Health, Inc.

Events and news impacting Quest Diagnostics Incorporated stock

Earnings, coporate decisions and industry developments that can affect the share price.

Quest Diagnostics Incorporated fundamentals and technical analysis

Financial fundamentals and technicals signals combined to access stability, momentum and market direction.